Case Study: a global leading pharmaceutical company strengthens rare disease competitive intelligence with Contify

Pharma Company Monitors Competitors’ Rare Disease Portfolio Developments to Identify Opportunities and Threats Using Contify

A global leading pharmaceutical company focused on rare disease treatments needed a better way to manage market and competitive intelligence across the organization. With information scattered across sources and too much manual effort required to sort through low-volume but critical rare disease signals, the company turned to Contify and its Market & Competitive Intelligence Platform to create a single source of truth for teams including R&D, market access, commercial, and business development.

Contify configured a tailored intelligence program with custom taxonomy, curated newsfeeds, email alerts, segmented newsletters, customized dashboards, and Microsoft Teams integration. The solution helped the company better track competitors, clinical trials, patents, regulatory updates, and market moves, leading to faster dissemination of insights, stronger cross-team alignment, accelerated R&D initiatives, more proactive collaborations, and more informed commercial actions that reinforced its leadership in rare diseases.